Bridge City Capital »

Tg Therapeutics shares owned by Bridge City Capital

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Bridge City Capital from 13F filings

Historical chart of Bridge City Capital investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Bridge City Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Bridge City Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 91k 33.22

More positions owned by Bridge City Capital

Ensign (ENSG)
Sterling Construction Company (STRL)
RBC Bearings Incorporated (RBC)
A10 Networks (ATEN)
Onto Innovation (ONTO)
Pacira Pharmaceuticals (PCRX)
Diodes Incorporated (DIOD)
LeMaitre Vascular (LMAT)
Modine Manufacturing (MOD)
Glacier Ban (GBCI)
Addus Homecare Corp (ADUS)
Iradimed (IRMD)
Amphastar Pharmaceuticals (AMPH)
M/a (MTSI)
Kulicke and Soffa Industries (KLIC)

View all positions for Bridge City Capital

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Soleus Capital Management
Geode Capital Management
ClearBridge Advisors
Jane Street
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Congress Asset Management
Pictet Asset Management Holding SA
Hood River Capital Management

View all funds holding Tg Therapeutics